Wasley; Jan W. F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wasley; Jan W. F..The latest application filed is for "therapeutic pyrazolonaphthyridine derivatives".

Company Profile

0.16.6

Wasley; Jan W. F. - Guilford CT
Wasley; Jan W. F. - Madison CT
Wasley; Jan W. F. - Essex CT
Wasley; Jan W. F. - Chatham NJ
Wasley; Jan W. F. - Ossining NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutic pyrazoloquinoline derivatives Grant 8,598,159 - Kaplan , et al. December 3, 2	2013-12-03
Therapeutic pyrazolonaphthyridine derivatives Grant 8,497,262 - Kaplan , et al. July 30, 2	2013-07-30
Therapeutic Pyrazoloquinoline Derivatives App 20110065693 - Kaplan; Alan P. ; et al.	2011-03-17
Therapeutic Pyrazolonaphthyridine Derivatives App 20110065692 - Kaplan; Alan P. ; et al.	2011-03-17
Therapeutic pyrazoloquinoline derivatives Grant 7,872,002 - Kaplan , et al. January 18, 2	2011-01-18
Therapeutic pyrazolonaphthyridine derivatives Grant 7,858,614 - Kaplan , et al. December 28, 2	2010-12-28
Therapeutic Pyrazolonaphthyridine Derivatives App 20090005365 - Kaplan; Alan P. ; et al.	2009-01-01
Therapeutic Pyrazoloquinoline Derivatives App 20080306049 - Kaplan; Alan P. ; et al.	2008-12-11
Novel 1-(N'-(arylalkylaminoalkyl)) aminoisoquinolines: a new class of dopamine receptor subtype App 20020052496 - He, Xiao-Shu ; et al.	2002-05-02
Certain 1- (2-naphthyl) and 1- (2- azanaphthyl) -4- (1-phenylmethyl) piperazines; dopamine receptor subtype specific ligands App 20020013317 - Greenlee, William ; et al.	2002-01-31
1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligands Grant 6,245,768 - He , et al. June 12, 2	2001-06-12
Certain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligands Grant 5,760,234 - Yuan , et al. June 2, 1	1998-06-02
Certain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligands Grant 5,478,934 - Yuan , et al. December 26, 1	1995-12-26
Pyrrolylphenyl-substituted hydroxamic acid derivatives Grant 5,096,919 - Wasley , et al. March 17, 1	1992-03-17
Certain pyrrolyl-substituted hydroxamic acid derivatives Grant 4,960,787 - Wasley October 2, 1	1990-10-02
4-Amino-substituted 1,2-dihydroxynaphthalene derivatives useful in inhibiting 5-lipoxygenase activity in mammals Grant 4,882,339 - Wasley November 21, 1	1989-11-21
Pyrrolo[1,2-a] [4,1]benzoxazepine derivatives useful as calmodulin and histamine inhibitors Grant 4,758,559 - Wasley , et al. July 19, 1	1988-07-19
Piperazinopyrrolobenzodiazepines Grant 4,316,900 - Wasley February 23, 1	1982-02-23
Substituted 4 Indazolaminoquinolines Grant 3,755,332 - Wasley , et al. August 28, 1	1973-08-28
Derivatives Of 4-[2-(carbocycloalkoxymethyl) Phenylimino]-1,4-dihydroquinolines Grant 3,679,687 - Wasley , et al. July 25, 1	1972-07-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.